DSM Invests in Probiotics Start Up

DSM says its subsidiary DSM Ventures and private equity firm Capital Resource Partners (Boston, MA) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements for digestive health. DSM and CSP have invested a combined total of $12 million. Further details about DSM’s share of the investment were not disclosed. Ganeden’s products are based on the use of a spore-forming and lactic-acid-producing bacterium, Bacillus coagulans. DSM says the investment will contribute to the company’s innovation ambitions in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers